Dr. Daniel Kune

As a joint venture between Aerogen Ltd. and Lyomark Pharma GmbH GenMar Pharma GmbH focusses on the production of a lead compound for both parent companies. With headquarter in Oberhaching (near Munich) and a quality control lab in Hannover my job is to secure the quality of the product establishing a QC laboratory for various standard and non standard analytical methods.

The task is to to set up an "innovations lab" which identifies new analytical trends in the fields of microbiology, molecular biology and chemical testing in the GMP-regulated environment. Prompted by our clients, the regulatory environment or through opportunities identified in house, the division "Innovations" will develop improvements to the existing portfolio and new methods by anticipating future demand. The methods developed will later be transferred to the routine GMP-Labs.

Direktor für die opperative Leitung, Verkauf von Produkten für die analytische und präparative Chromatographie

Business development for silica based chromatographic material. The silica is produced and modyfied by YMC in Japan. I am responsible for bulk in the EMEA

as at Imperial College (2x 6 month visit at project partner UAL)

Silver ion Chromatography, Invention: dense membrane separator. Extraction and purification of polyunsaturated fatty acis from marine algae

Analytische Chromatographie, Grundlegende Untersuchungen zur Kopplung der Kapillar-Elektrophorese mit der matrix unterstützten LASER-desorption ionisierung Massen Spektrometrie (MALDI-MS).